It has been noticeable in recent weeks how various brokers have been attempting to get on the bandwagon in terms of the smaller oil stocks/private investor favourites in the oil & gas area.
On April 23rd when Frontera Resources were trading at 0.9p I suggested that they might double within three months. In fact, they only rose 50% in five weeks before the rug was pulled yesterday. Can this be classed as a failure of charting?
The pain in Spain falls mainly on….everybody. But right now it is investors in a range of solar schemes that are taking an almighty beating and there is a lesson and warning here for anyone considering backing any one of those numerous solar or wind schemes you see flagged as sure-fire winners across the globe.
Last month, with its shares at 15.625p, I concluded here that the risk-reward trade off with China-focused, AIM and Aussie listed, gas explorer Leyshon Resources (LRL) continued to look attractive. The company has since announced what it emphasises as “a very encouraging early step in de-risking” its Zijinshan gas project.
The U.S. Comex gold futures rebounded 1.33 percent in the past two days to $1,415.80 on Thursday while the Dollar Index plunged 1.49 percent to finish at 81.537 on Thursday.
Are you may imagine, being a Chartist I have no other means of determining the merits of a company other than the squiggles on the screen in front of me. In the case of Fastjet it had been apparent that a recovery was on the cards, it was simply a question of timing as to when the shares would break the parameters of a bullish falling wedge formation which has been on the daily chart since the beginning of the year.
On 23rd May it was announced that Parkmead (PMG) was to buy Lochard Energy (LHD) in an all share deal worth c 4.9p per share. 41% of Lochard shareholders have agreed unconditionally but some – including the former CEO are trying to block the deal.
Notwithstanding its profits warning earlier this week AIM listed gold producer Goldplat will maintain its dividend claims house broker SP Angel and thus at 7p the stock yields 8.6%.
Alliance Pharma (APH) is in the news today as it has announced an $11.5 million (£7.5 million) acquisition of all existing rights to the ‘Syntometrine’ drug from industry major Novartis
Sanderson Group (SND), the AIM-listed software and IT services company specialising in the multi-channel retail and manufacturing markets in the UK and Ireland, has announced a pre-tax profit from continuing operations of £0.852 million (up from £0.624 million) on revenue up 3.7%, at £6.37 million, generating earnings per share of 1.84p (up from 0.87p) for the six months ended 31st March 2013.
I offer no comment on this weekly feature it is a simple matter of observation. The two tables below show the most active discussions on the ADVFN and iii Bulletin Boards as of a Thursday morning.
Specialty pharmaceutical company Alliance Pharma (APH) has today announced an $11.5 million (£7.5 million) acquisition of all existing rights to the ‘Syntometrine’ drug from industry major Novartis. This is part of its strategy of buying in “orphan” brands from majors which it can then monetize by flogging through its existing sales infrastructure.
Ostensibly the interim numbers released late last month by AIM-listed collectibles company Noble Investments (NBL) didn’t make positive reading – showing a pre-tax profit down from £2.42 million in the comparative prior year period to £0.504 million on revenue, excluding a £1.39 million contribution from the December acquired Fine Art Auction Group Ltd, 4.5% lower.
Specialist environmental support services group Silverdell (LSE: SID) announced its results for the six months ended 31st March 2013 yesterday.
Although it can be seen from the daily chart of Cyan over the past couple of years that the shares and their road to recovery have been peppered with false starts, traps and gaps, through all the noise we still have the fact that 2013 support above 0.4p was a major higher low versus the multiple bear traps over the middle of last year.
Premier Gold Resources is not a stock which was on my personal radar in terms of potential recovery situations. However, it was offered up to me by a kindly Twitter follower. What can be seen on the daily chart currently is that we appear to be in the run-up to a combination of a bear trap reversal, and a W-shaped rebound contender.
Perhaps more than anything else what gives charting a bad reputation is when what appears to be the perfect formation/pattern then goes and gives traders a slap in the face.
There are some recovery situations where a great deal of head scratching and soul-searching is required to finally plucked up the courage and press the buy button. However, it would appear that after an exceedingly long wait Cadogan Petroleum as returned as a likely share price revival contender, and done so in style.
It is quite clear from the daily chart of African Eagle in recent months and years that this is certainly not the type stock that dreams are made of, unless of course you are a bear.
FTSE-250 engineering, procurement, construction and technical support services group, Kentz (KENZ) has announced it has been awarded its “largest US contract to date” - this for the Point Thomson gas cycling and condensate production plant in Alaska.
The May edition of the UK Investor Show Magazine is live featuring three share tips from Gary Newman, the Greek meltown is worse than everyone thinks, and the EU is not fit for purpose plus a photofeature from the 2017 UK Investor Show.
The busting of a placing by AIM-listed UK Oil and Gas (UKOG) at 1p by Tom Winnifrith has caused a bit of controversy. It is not the first time he has been accused of being irresponsible by blowing the lid on a placing only for it to be pulled or the price dropped. Anyone left holding the baby gets their fingers burned – in the recent example quite badly if they had been buying into the ramp at north of 1.4p only to see the company raise cash at just 0.8p. Is it right?
The nauseating Mail on Sunday fawned upon Pippa Middleton and her ghastly family as they celebrated the "wedding of the Year". Bring on the revolution! But perhaps the real wedding of the year should be between our two very own in-house Bulletin Board Morons GrannySnuffs & Wildes who seem made for each other. can you find examples on the LSE Asylum, iii, ADVFN or twitter of comments more idiotic than those of our own dream team? If so post in the comments section below, the deadline is midnight Sunday 28th May.
Having bought itself some time by declaring an initial sack-the-board General Meeting requisition “invalid” (a revised, valid requisition announced by it at an attempted ‘no one watching o’clock’, 5:15 pm, on Friday), Infrastrata (INFA) has this afternoon made a “Review of stategic options & project update” announcement...
AIM-listed travel agent and wannabe Greek holiday resort developer Minoan (MIN) announced a small bolt-on acquisition this morning….and a placing. Oh, and an update on its debt facility due to expire at the end of June. It is disappointing to see a placing (at 9p), but in the general scheme of things it is a relatively small amount so the pill is sugared to some extent.
It was a keen competition this week. But we have found a winner.
Take a look! European investors are clearly failing to grasp the very significant financial and commercial benefits available for Orphan or Rare Disease drug developers. So much so in fact, that sector-focussed Amryt Pharma (AMYT) finds no quoted peers in London, yet a good basket of NASDAQ-listed comparables are seen to command a significant premium despite mostly being pre-revenue and somewhat earlier in their development. Such anomalies can and, of course, do rapidly correct.
Any reader of my pieces will know I hold Challenger Acquisitions (CHAL) in pretty low regard but the outrageous ramping that has now gone on for the last four trading days is an absolute disgrace and the FCA should take a look. I’ll explain.
I have already covered the dire financials of Eden Research that indicate it is just months from trading whilst insolvent as well as its panning by the Financial Reporting Council (FRC) - in response to my urgings. Now to today's monstrous half truths - I am perhaps being 50% too charitable in that description.
Eden Research (EDEN) has today published godawful results and admitted that my very good friends at the Financial Reporting Council (FRC) investigated it - after I requested such an investigation - and have forced it to restate past numbers. It claims that the FRC has now settled all matters. Au contraire. that is another lie from the fraudsters and there are many more porkies in this statement. Truly, the pants of shamed PR Paul Queenie McManus of Walbrook will be cinders and ash after this effort. This all came out as Eden published Godawful numbers for calendar 2016.
The sold-out success that was the 1st April 2017 UK Investor Show again saw five 'Dragon's Den' sessions where a number of CEOs each gave a pitch and three Dragons each picked one stock for a £1,000 investment. How are they faring so far?...
With some great investigative journalism of which this website would have been proud, Brokerman Dan flushed it out a few weeks ago. The former bank robber - correctly - stated that Andalas (ADL) was looking to raise £1 million at 0.06p and the AIM listed crock of shit suspended its shares. Today they are unsuspended after the company raised £600,000 at 0.1p. It says this is at a premium to the suspension price. But it is a spoof, Andalas is still bust. It is insolvent as of today!
Malcolm Stacey is old enough to know about King Canute. In fact he is so old that he was there as a boy when the King sat in his chair on the beach and attempted to turn back the tide. Malcolm surely you remember the day as if it was yesterday? In which case why do you forget this valuable lesson when it comes to Inmarsat (ISAT) and your article today in which you misquote me and get it wrong in so many other ways.
"A credit crunch is brewing and when it happens, the UK is going to get hurt." These are not my words but the start of the Editorial in this weekend’s Guardian. The article then went on to say "That is the message emerging from senior executives in the financial services industry, who do not think Britain has changed that much since the 2008 credit disaster and the devastating crash that followed. Three developments lie at the heart of this disturbing analysis: spectacular growth in the sale of second mortgages, car loans and credit cards." I would heartily agree with these comments as this is my experience too. But what the article fails to say is that the UK is not alone in this debt bubble - once more it is a Global issue.
Hello Share Scoopers. There have been quite a few occasions now that I’ve commended a Footsie satellite company to your attention. On each mention, as I recall, the share grew in value. However, last year the shares took a big knock.
One of the most fascinating scenes I’ve seen for some time is the sight of Big Donald jigging around with some sort of weird entertainment put on by the Saudi’s for the President's visit. It almost made me forget the big benefit of this amiable state visit on share shifters like us. And that of course is that the President’s friendly reception sent the oil price up.
An announcement from Corero Network Security (CNS) with a headline “Corero Tier 1 Internet service provider customer GTT Communications, Inc. launches DDoS Mitigation service”. Then “further to the announcement on 19 April 2017 regarding a Global Tier 1 Internet service provider customer win… announces that the customer, GTT Communications, Inc. (NYSE: GTT), has launched its DDoS Mitigation service”. “Global Tier 1” now hey! And you what? The contract win has already been announced? Ramptastic…
Together Robert Sutherland Smith and Tom Winnifrith have now been working in finance for 71 years - the last ten or so together. Tom wishes to stress that RSS accounts for most of that, the great value investor starting his City career at the Unilever Pension Fund the year before Tom was born. In this book they outline 71 tricks of the trade for making money from shares.
Get the first ShareProphets Pocket Guide ebook, EIS - Buying shares with numerous tax breaks. Want to cut your income tax bill, get loss relief if your AIM listed shares go down, pay no CGT, avoid IHT - EIS could be the way and this book explains how.
Most investment books seem to be large enough to keep the front door open and while some contain gems it is hard to find them amid the verbiage. The aim here is to produce a short guide which simply cuts to the chase. I hope that it will provide food for thought for everyone from beginner to expert but whoever you are it should be quick and easy to read and digest.
Search ShareProphets |
Stock market news |
Recent Comments |